Arrowhead Research | ARWR - 股票



金融业
股票价格
USD
资产
USD 2.27B
现金及等价物
USD 201.64M
流动资产
USD 1.84B
流动负债
USD 295.22M
债务
USD 312.77M
EBIT
USD -141.26M
EBITDA
USD 57.17M
员工
711
EPS每股收益
USD -0.93
股本和储备
USD 613.98M
销售毛利
USD 264.03M
债务利息支出
USD 22.51M
利息收入
USD 9.69M
贷款资金
USD 1.23B
市值
USD 9.71B
净收入
USD -132.73M
营业费用
USD 215M
营业利润
USD -141.26M
普通股股本
USD 137.39M
PE价格收益
41.67
税前利润
USD 28.27M
销售收入
USD 73.74M
销售和管理费用
USD 41.74M
股票
USD -173.09M
贸易债权人
USD 30.75M
应收帐款人
USD 15.69M


股票 更改 日
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
Anika Therapeutics USD 22.84M 4.05M 2026-03
Arrowhead Research USD -173.08M 173.08M 2024-12
Heron Therapeutics USD 54.57M 2.33M 2022-12
Incyte USD 115.62M 14.56M 2026-03
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
Ligand Pharmaceuticals USD 13.27M 4.14M 2026-03
Merck USD 6.48B 179M 2026-03
Moderna USD 146M 7M 2026-03
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Novartis USD 6.29B 17M 2026-03
Sarepta Therapeutics USD 1B 86.37M 2026-03
TG Therapeutics USD 129.03M 3.44M 2026-03
Ultragenyx Pharmaceutical USD 55M 3M 2026-03
Vertex Pharmaceuticals USD 1.77B 79.9M 2026-03